Replimune Group, Inc. (REPL)
9.82
-0.48
(-4.66%)
USD |
NASDAQ |
Dec 10, 16:00
9.60
-0.22
(-2.24%)
After-Hours: 04:43
Replimune Group Shareholders Equity (Quarterly): 263.34M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Rapt Therapeutics, Inc. | 151.98M |
| Olema Pharmaceuticals, Inc. | 307.49M |
| CorMedix, Inc. | 374.13M |
| Verastem, Inc. | -15.53M |
| Anavex Life Sciences Corp. | 94.87M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 389.45M |
| Total Liabilities (Quarterly) | 126.11M |
| Debt to Equity Ratio | 0.2898 |
| Current Ratio | 6.309 |
| Net Debt Paydown Yield | -0.02% |